Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
Coleman, R., de Boer, R., Eidtmann, H., Llombart, A., Davidson, N., Neven, P., von Minckwitz, G., Sleeboom, H.P., Forbes, J., Barrios, C., Frassoldati, A., Campbell, I., Paija, O., Martin, N., Modi, A., Bundred, N.
Published in Annals of oncology (01.02.2013)
Published in Annals of oncology (01.02.2013)
Get full text
Journal Article
0132 The effect of zoledronic acid in postmenopausal women (PMW) with early breast cancer (EBC) receiving adjuvant letrozole: 24 months integrated follow-up of the Z-FAST/ZO-FAST trials
Frassoldati, A, Brufsky, A, Bundred, N, Lambert-Falls, R, Hadji, P, Schenk, N, Paija, O, Mena, R, Coleman, R
Published in Breast (Edinburgh) (2009)
Published in Breast (Edinburgh) (2009)
Get full text
Journal Article
Cost-Effectiveness of Adding Zoledronic Acid to Endocrine Therapy in Premenopausal Women with Hormone-Responsive Early Breast Cancer in Sweden, Norway, Denmark, and Finland, Based on the ABCSG-12 Study
Taneja, C., Lindman, H., Paija, O., Kamby, C., Kaura, S., Jnosson, L., Delea, T.
Published in Cancer research (Chicago, Ill.) (15.12.2009)
Published in Cancer research (Chicago, Ill.) (15.12.2009)
Get full text
Journal Article
Entacapone increases levodopa exposure and reduces plasma levodopa variability when used with Sinemet CR
Paija, Outi, Laine, Kari, Kultalahti, Eeva-Riitta, Leinonen, Mika, Huupponen, Risto, Gordin, Ariel, Reinikainen, Kari
Published in Clinical neuropharmacology (01.05.2005)
Published in Clinical neuropharmacology (01.05.2005)
Get more information
Journal Article
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
Coleman, R, de Boer, R, Eidtmann, H, Llombart, A, Davidson, N, Neven, P, von Minckwitz, G, Sleeboom, H P, Forbes, J, Barrios, C, Frassoldati, A, Campbell, I, Paija, O, Martin, N, Modi, A, Bundred, N
Published in Annals of oncology (01.02.2013)
Get full text
Published in Annals of oncology (01.02.2013)
Journal Article
Phase III, randomized study of docetaxel (T) + capecitabine (X) (TX) followed by cyclophosphamide (C) + epirubicin (E) + X (CEX) vs. T followed by C + E + fluorouracil (F) (CEF) as adjuvant treatment for patients (pts) with early breast cancer (BC): An interim safety analysis
Joensuu, H., Hemminki, A., Tanner, M., Paija, O., Kokko, R., Asola, R., Johansson, K., Bono, P., Elomaa, I., Kellokumpu-Lehtinen, P.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article